mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
-0.094 |
0.08 |
mRNA |
indisulam |
CTRPv2 |
pan-cancer |
AAC |
-0.059 |
0.08 |
mRNA |
SB-743921 |
CTRPv2 |
pan-cancer |
AAC |
-0.059 |
0.08 |
mRNA |
PI-103 |
CTRPv2 |
pan-cancer |
AAC |
-0.063 |
0.08 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.063 |
0.09 |
mRNA |
Dasatinib |
CTRPv2 |
pan-cancer |
AAC |
0.064 |
0.09 |
mRNA |
elocalcitol |
CTRPv2 |
pan-cancer |
AAC |
-0.06 |
0.1 |
mRNA |
BRD-M00053801 |
CTRPv2 |
pan-cancer |
AAC |
-0.082 |
0.1 |
mRNA |
Docetaxel |
gCSI |
pan-cancer |
AAC |
-0.092 |
0.1 |
mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.061 |
0.1 |